187 related articles for article (PubMed ID: 14971160)
1. [Statin therapy is a basic treatment for coronary heart disease].
Gurevich MA
Klin Med (Mosk); 2003; 81(12):60-2. PubMed ID: 14971160
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of intensive statin therapy in the elderly.
Maroo BP; Lavie CJ; Milani RV
Am J Geriatr Cardiol; 2008; 17(2):92-100. PubMed ID: 18326948
[TBL] [Abstract][Full Text] [Related]
3. Statins and the acute-phase response.
Munford RS
N Engl J Med; 2001 Jun; 344(26):2016-8. PubMed ID: 11430332
[No Abstract] [Full Text] [Related]
4. Current questions regarding the use of statins in patients with coronary heart disease.
Rallidis LS; Lekakis J; Kremastinos DT
Int J Cardiol; 2007 Nov; 122(3):188-94. PubMed ID: 17399827
[TBL] [Abstract][Full Text] [Related]
5. Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study).
Tikkanen MJ; Holme I; Cater NB; Szarek M; Faergeman O; Kastelein JJ; Olsson AG; Larsen ML; Lindahl C; Pedersen TR;
Am J Cardiol; 2009 Mar; 103(5):577-82. PubMed ID: 19231315
[TBL] [Abstract][Full Text] [Related]
6. [Optimal lipid lowering therapy for coronary heart diseases patients in secondary prevention: moderate or aggressive LDL decrease preferred?].
MMW Fortschr Med; 2006 Nov; 148(48):54-5. PubMed ID: 17615773
[No Abstract] [Full Text] [Related]
7. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
8. Pravastatin and coronary heart disease.
Meyer FP
N Engl J Med; 1999 Apr; 340(14):1115-6; author reply 1116-7. PubMed ID: 10206830
[No Abstract] [Full Text] [Related]
9. Treating low HDL-cholesterol in normocholesterolaemic patients with coronary disease: statins, fibrates or horses for courses?
Watts GF
Eur Heart J; 2004 May; 25(9):716-9. PubMed ID: 15120879
[No Abstract] [Full Text] [Related]
10. [Statins inhibit inflammatory reaction. CRP advances as a marker of coronary risk].
MMW Fortschr Med; 2000 Jul; 142(28-29):54-5. PubMed ID: 10959166
[No Abstract] [Full Text] [Related]
11. C-reactive protein, coronary risk, and statins.
Harv Womens Health Watch; 2001 Sep; 9(1):2. PubMed ID: 11572835
[No Abstract] [Full Text] [Related]
12. Pravastatin and coronary heart disease.
Bloom JM
N Engl J Med; 1999 Apr; 340(14):1116-7. PubMed ID: 10206831
[No Abstract] [Full Text] [Related]
13. Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event.
Brudi P; Reckless JP; Henry DP; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO
Cardiology; 2009; 113(2):89-97. PubMed ID: 19018143
[TBL] [Abstract][Full Text] [Related]
14. Benefits of the statins: beyond cholesterol.
Harv Mens Health Watch; 2001 Aug; 6(1):1-5. PubMed ID: 11546633
[No Abstract] [Full Text] [Related]
15. [For coronary disease patients is certain: the lower the LDL the better].
MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
[No Abstract] [Full Text] [Related]
16. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
LaRosa JC; Grundy SM; Kastelein JJ; Kostis JB; Greten H;
Am J Cardiol; 2007 Sep; 100(5):747-52. PubMed ID: 17719314
[TBL] [Abstract][Full Text] [Related]
17. Early effects of statins in patients with coronary artery disease and high C-reactive protein.
Muhlestein JB; Anderson JL; Horne BD; Carlquist JF; Bair TL; Bunch TJ; Pearson RR;
Am J Cardiol; 2004 Nov; 94(9):1107-12. PubMed ID: 15518602
[TBL] [Abstract][Full Text] [Related]
18. Multiple complex coronary plaques in patients with acute myocardial infarction.
Wascher TC; deCampo A; Schmoelzer I
N Engl J Med; 2001 Feb; 344(7):527-8. PubMed ID: 11221614
[No Abstract] [Full Text] [Related]
19. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
20. Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event?
Goyal A; Blazing M
Am Heart J; 2005 Oct; 150(4):650-1. PubMed ID: 16209959
[No Abstract] [Full Text] [Related]
[Next] [New Search]
